Amyloid beta (Aβ) is a peptide implicated in Alzheimer's disease and other forms of dementia. It forms when amyloid precursor protein (APP) is improperly cleaved by enzymes. Accumulating Aβ peptides aggregate into plaques, a hallmark of Alzheimer's pathology. These plaques disrupt cell function, trigger inflammation, and promote neuronal death, contributing to cognitive decline and memory loss. Research aims to understand the mechanisms of Aβ formation and aggregation, seeking therapeutic strategies to prevent or reduce plaque buildup. Despite its central role in Alzheimer’s, the exact relationship between amyloid beta and disease progression remains complex, involving genetic, environmental, and biochemical factors.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States